retatrutide triple agonist glp-1 gip glucagon receptor #retatrutide is a novel peptide at the receptor, receptor, and receptor. 22-24% weight loss at 48 weeks with a similar tolerability profile to #tirzepatide. @LillyPad #medtwitter #endotwitter https://t.co/duYwW0EcmF The power of three: Retatrutide's

Pen-format dosing reduces reconstitution error versus lyophilised vials, which matters when the glucagon arm's GI tolerance window is narrow

Meeting highlights from the pharmacovigilance risk assessment committee (PRAC)

If the follow-up appointment takes place with a specialist, the specialist provider must share the patients follow-up visit notes with the primary care PCMH provider to meet this requirement

Fewer worries about daytime nausea: Taking your injection at night may allow you to sleep through any mild nausea or discomfort, making the adjustment period easier to manage

All products sold by Beyond Health Lab are intended strictly for in vitro research and laboratory use only